Miyuki Nakagawa Selected Research

Interferons

12/2004

Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miyuki Nakagawa Research Topics

Disease

11	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 05/2021
5	Neoplasms (Cancer) 03/2023 - 04/2020
3	Hypertension (High Blood Pressure) 10/2023 - 01/2023
3	Proteinuria 10/2023 - 01/2023
2	Infections 10/2022 - 08/2005
1	Portal Hypertension 04/2024
1	Hepatic Encephalopathy 04/2024
1	Ascites 04/2024
1	Clinical Deterioration 03/2023
1	Carcinogenesis 03/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Pulmonary Arterial Hypertension 01/2023
1	Diabetes Mellitus 01/2023
1	Hepatitis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Liver Neoplasms (Liver Cancer) 09/2022
1	Microsatellite Instability 11/2021
1	Carcinoma (Carcinomatosis) 04/2020
1	Sensorineural Hearing Loss 01/2020
1	Wounds and Injuries (Trauma) 11/2019
1	Pulmonary Hypertension 11/2019
1	Abdominal Pain (Pain, Abdominal) 11/2019
1	Hematoma 11/2019
1	Bacterial Infections (Bacterial Infection) 08/2005
1	Fetal Death 12/2004

Drug/Important Bio-Agent (IBA)

4	Bevacizumab (Avastin)FDA Link 03/2023 - 01/2022
4	atezolizumabIBA 03/2023 - 01/2022
3	Immune Checkpoint InhibitorsIBA 03/2023 - 11/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 11/2021
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 10/2023 - 01/2023
2	camostatIBA 10/2023 - 01/2023
2	Fibrinolysin FDA Link 10/2023 - 01/2023
2	SaltsIBA 10/2023 - 01/2023
2	Sorafenib (BAY 43-9006)FDA Link 07/2023 - 03/2023
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2023 - 04/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
1	AlbuminsIBA 04/2024
1	AmmoniaIBA 04/2024
1	cabozantinibIBA 07/2023
1	RamucirumabIBA 03/2023
1	micaIBA 03/2023
1	LigandsIBA 03/2023
1	MHC class I-related chain AIBA 03/2023
1	ceramide glucosyltransferaseIBA 01/2023
1	miglustat (Zavesca)FDA Link 01/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023
1	CollagenIBA 01/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	CytokinesIBA 01/2023
1	AntigensIBA 10/2022
1	tranilastIBA 10/2022
1	GelatinIBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	durvalumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	tremelimumabIBA 01/2022
1	pembrolizumabIBA 11/2021
1	lenvatinibIBA 05/2021
1	Warfarin (Coumadin)FDA LinkGeneric 11/2019
1	Meropenem (Merrem)FDA LinkGeneric 08/2005
1	tomopenemIBA 08/2005
1	Vancomycin FDA LinkGeneric 08/2005
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2005
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2005
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 08/2005
1	Polychlorinated Dibenzodioxins (TCDD)IBA 12/2004
1	InterferonsIBA 12/2004

Therapy/Procedure

6	Therapeutics 04/2024 - 11/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2024
1	Aftercare (After-Treatment) 03/2023
1	Precision Medicine 09/2022
1	Punctures 09/2022
1	Immunotherapy 01/2022
1	Heavy Ion Radiotherapy 05/2021
1	Surgical Instruments (Clip) 04/2020